Synopsis
Synopsis
0
KDMF
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. A-hyrocort
2. Cortisol Hemisuccinate
3. Cortisol Succinate
4. Cortisol Succinate, Sodium Salt
5. Cortisol-21-(hydrogen Succinate)
6. Hydrocortisone 21-sodium Succinate
7. Hydrocortisone Hemisuccinate
8. Hydrocortisone Hemisuccinate Anhydrous
9. Hydrocortisone Succinate
10. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11beta)-
11. Solu-cortef
12. Sopolcort H
13. Sopolkort
1. 125-04-2
2. A-hydrocort
3. Hydrocortisone 21-hemisuccinate Sodium Salt
4. Cortop
5. Solu-cortef
6. Arcocort
7. Buccalsone
8. Corlan
9. Emi-corlin
10. Cortisol 21-(sodium Succinate)
11. Flebocortid
12. Hycorace
13. Intracort
14. Nordicort
15. Oralsone
16. Solu-hizon
17. Solu-glyc
18. Hydrocortisone 21-sodium Succinate
19. Ef-cortelan Soluble
20. 50lqb69s1z
21. Chebi:5782
22. Cortisol Sodium Succinate
23. Hydrocortisone Hemisuccinate
24. Cortisol Sodium Hemisuccinate
25. Sodium Hydrocortisone Succinate
26. Cortisol Hemisuccinate Sodium Salt
27. Hydrocortisone Sodium Hemisuccinate
28. Hydrocortisone 21-sodium Succinide
29. Sodium Hydrocortisone 21-succinate
30. Nsc-9152
31. Hydrocortisone 21-hemisuccinate Sodium
32. Hydrocortisone Sodium 21-hemisuccinate
33. Sodium Hydrocortisone 21-hemisuccinate
34. Hydrocortisone Hemisuccinate Sodium Salt
35. Dsstox_cid_28932
36. Dsstox_rid_83198
37. Dsstox_gsid_49006
38. Hydrocortisone 21-succinate Sodium Salt
39. Sodium 17-hydroxycorticosterone 21-succinate
40. Hidrokortizon
41. U 4905
42. Nositrol
43. Rapicort
44. Lycortin-s
45. Cas-125-04-2
46. Sodium;4-[2-[(8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate
47. Flebocortid [inj.]
48. Hydro-adreson Aquosum
49. Ncgc00022248-03
50. Idrocortisone B. I. L.
51. Unii-50lqb69s1z
52. Hydrocortisone Succinate,sodium Salt
53. Einecs 204-725-5
54. A-hydrocort (tn)
55. Solu-cortef (tn)
56. Hydrocortisone 21-(sodium Succinate)
57. Mfcd00069472
58. Hydrocortisone-21-hemisuccinate Sodium
59. Hydrocortisone-21-hemisuccinate Sodium Salt
60. Cortisol 21-hemisuccinate Sodium Salt
61. Hydrocortisone Sodium Succinate [usp:ban:jan]
62. Schembl93508
63. Hydrocortisoni Natrii Succinas
64. Mls000069545
65. Chembl1200495
66. Dtxsid2049006
67. Cortisol 21-hemisuccinate Sodium
68. Hms2234h22
69. Succinic Acid Hydrocortisone Sodium
70. Tox21_113501
71. Akos024386298
72. Tox21_113501_1
73. Cortisol, Succinate, Sodium Salt
74. Ncgc00022248-04
75. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, Monosodium Salt, (11.beta.)-
76. Smr000058768
77. Eu-0100623
78. Hydrocortisone Sodium Succinate (jp17/usp)
79. Hydrocortisone Sodium Succinate [jan]
80. U4905
81. C08178
82. D00978
83. F20569
84. H 2270
85. Hydrocortisone Sodium Succinate [mart.]
86. Hydrocortisone Sodium Succinate [vandf]
87. Hydrocortisone 21-sodium Succinate [mi]
88. Hydrocortisone Sodium Succinate [who-dd]
89. Hydrocortisone Sodium Succinate [who-ip]
90. Cortisol, 21-(hydrogen Succinate), Monosodium Salt
91. Hydrocortisone Sodium Succinate [orange Book]
92. Hydrocortisone Sodium Succinate [usp Monograph]
93. Hydrocortisoni Natrii Succinas [who-ip Latin]
94. Q27106890
95. Hydrocortisone 21-hemisuccinate Sodium Salt, >=90% (hplc)
96. Hydrocortisone 21-hemisuccinate Sodium Salt, Powder, Bioreagent, Suitable For Cell Culture
97. (11beta)-21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxypregn-14-ene-3,20-dione, Monosodium Salt
98. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, Monosodium Salt, (11beta)-
Molecular Weight | 484.5 g/mol |
---|---|
Molecular Formula | C25H33NaO8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 484.20731229 g/mol |
Monoisotopic Mass | 484.20731229 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 915 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | A-hydrocort |
PubMed Health | Hydrocortisone (Injection) |
Drug Classes | Endocrine-Metabolic Agent, Immune Suppressant |
Active Ingredient | Hydrocortisone sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 100mg base/vial |
Market Status | Prescription |
Company | Hospira |
2 of 4 | |
---|---|
Drug Name | Solu-cortef |
PubMed Health | Hydrocortisone |
Drug Classes | Anti-Inflammatory, Corticosteroid, Intermediate, Corticosteroid, Weak, Endocrine-Metabolic Agent, Gastrointestinal Agent, Hemorrhoidal Anti-Inflammatory, Hydrocortisone, Immune Suppressant |
Drug Label | SOLU-CORTEF Sterile Powder is an anti-inflammatory glucocorticoid that contains hydrocortisone sodium succinate as the active ingredient. SOLU-CORTEF Sterile Powder is available in several packages for intravenous or intramuscular administration.100... |
Active Ingredient | Hydrocortisone sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial; eq 250mg base/vial; eq 1gm base/vial; eq 100mg base/vial |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
3 of 4 | |
---|---|
Drug Name | A-hydrocort |
PubMed Health | Hydrocortisone (Injection) |
Drug Classes | Endocrine-Metabolic Agent, Immune Suppressant |
Active Ingredient | Hydrocortisone sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 100mg base/vial |
Market Status | Prescription |
Company | Hospira |
4 of 4 | |
---|---|
Drug Name | Solu-cortef |
PubMed Health | Hydrocortisone |
Drug Classes | Anti-Inflammatory, Corticosteroid, Intermediate, Corticosteroid, Weak, Endocrine-Metabolic Agent, Gastrointestinal Agent, Hemorrhoidal Anti-Inflammatory, Hydrocortisone, Immune Suppressant |
Drug Label | SOLU-CORTEF Sterile Powder is an anti-inflammatory glucocorticoid that contains hydrocortisone sodium succinate as the active ingredient. SOLU-CORTEF Sterile Powder is available in several packages for intravenous or intramuscular administration.100... |
Active Ingredient | Hydrocortisone sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial; eq 250mg base/vial; eq 1gm base/vial; eq 100mg base/vial |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Hydrocortisone Sodium Succinate
About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...
Hydrocortisone Sodium Succinate
About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...
Hydrocortisone Sodium Succinate
About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
Hydrocortisone Sodium Succinate
About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
Hydrocortisone Sodium Succinate
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
Hydrocortisone Sodium Succinate
About the Company : Bioquim is a European company specializing in bulk oral & sterile APIs for the pharmaceutical industry. With over 40 years of experience, we offer high-quality corticosteroids, pep...
Hydrocortisone Sodium Succinate
About the Company : Established in 2010, Mac-Chem is a NMM Group company. Mac-Chem is focused on oncology and other niche specialty APIs. It supplies quality APIs to the top 15 oncology players in Ind...
Hydrocortisone Sodium Succinate
About the Company : NEWCHEM is an independent Italian manufacturer of Active Pharmaceutical Ingredients (APIs) - Steroids, Progestogens, Prostafglandins. NEWCHEM is active on the worldwide Pharmaceut...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-, including repackagers and relabelers. The FDA regulates Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- supplier is an individual or a company that provides Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- active pharmaceutical ingredient (API) or Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- finished formulations upon request. The Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers may include Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- API manufacturers, exporters, distributors and traders.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- DMF (Drug Master File) is a document detailing the whole manufacturing process of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- active pharmaceutical ingredient (API) in detail. Different forms of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- DMFs exist exist since differing nations have different regulations, such as Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- DMF submitted to regulatory agencies in the US is known as a USDMF. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- USDMF includes data on Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- Drug Master File in Japan (Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- JDMF) empowers Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- JDMF during the approval evaluation for pharmaceutical products. At the time of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with JDMF on PharmaCompass.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP of the European Pharmacopoeia monograph is often referred to as a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- Certificate of Suitability (COS). The purpose of a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- to their clients by showing that a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP has been issued for it. The manufacturer submits a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP holder for the record. Additionally, the data presented in the Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- DMF.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with CEP (COS) on PharmaCompass.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- written confirmation (Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- WC) is an official document issued by a regulatory agency to a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- manufacturer, verifying that the manufacturing facility of a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- APIs or Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- finished pharmaceutical products to another nation, regulatory agencies frequently require a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- WC (written confirmation) as part of the regulatory process.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- suppliers with NDC on PharmaCompass.
Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- GMP manufacturer or Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- GMP API supplier for your needs.
A Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CoA (Certificate of Analysis) is a formal document that attests to Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-'s compliance with Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- specifications and serves as a tool for batch-level quality control.
Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CoA mostly includes findings from lab analyses of a specific batch. For each Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- may be tested according to a variety of international standards, such as European Pharmacopoeia (Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- EP), Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- USP).
LOOKING FOR A SUPPLIER?